Clinical trial
A Study of Novel Immune Modulating Biomarkers in Patients With Spondyloarthritis With Axial Involvement
NCT01969188 is registered in ClinicalTrials.gov with Hospital for Special Surgery, New York as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Study of Novel Immune Modulating Biomarkers in Patients With Spondyloarthritis With Axial Involvement
- Lead sponsor
- Hospital for Special Surgery, New York
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2013
- Completion date
- December 18, 2025
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
spondyloarthritis